Application of 3D bioprinting in the prevention and the therapy for human diseases

HG Yi, H Kim, J Kwon, YJ Choi, J Jang… - Signal Transduction and …, 2021 - nature.com
Rapid development of vaccines and therapeutics is necessary to tackle the emergence of
new pathogens and infectious diseases. To speed up the drug discovery process, the …

Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update

U Anand, S Jakhmola, O Indari, HC Jha… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …

[HTML][HTML] Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

B Korber, WM Fischer, S Gnanakaran, H Yoon… - BioRxiv, 2020 - biorxiv.org
We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-
CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human …

Time series prediction of COVID-19 by mutation rate analysis using recurrent neural network-based LSTM model

RK Pathan, M Biswas, MU Khandaker - Chaos, Solitons & Fractals, 2020 - Elsevier
Abstract SARS-CoV-2, a novel coronavirus mostly known as COVID-19 has created a global
pandemic. The world is now immobilized by this infectious RNA virus. As of June 15, already …

Using artificial intelligence techniques for COVID-19 genome analysis

MS Nawaz, P Fournier-Viger, A Shojaee, H Fujita - Applied Intelligence, 2021 - Springer
The genome of the novel coronavirus (COVID-19) disease was first sequenced in January
2020, approximately a month after its emergence in Wuhan, capital of Hubei province …

Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus)

TT Nguyen, PN Pathirana, T Nguyen, QVH Nguyen… - Scientific Reports, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic
virus that has caused the global COVID-19 pandemic. Tracing the evolution and …

A comprehensive review about the molecular structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insights into natural products against …

EM Saied, YA El-Maradny, AA Osman, AMG Darwish… - Pharmaceutics, 2021 - mdpi.com
In 2019, the world suffered from the emergence of COVID-19 infection, one of the most
difficult pandemics in recent history. Millions of confirmed deaths from this pandemic have …

Immunotherapeutic approaches to curtail COVID-19

H Owji, M Negahdaripour, N Hajighahramani - International …, 2020 - Elsevier
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …

Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects

HT Nguyen, S Zhang, Q Wang, S Anang… - Journal of …, 2021 - Am Soc Microbiol
ABSTRACT SARS-CoV-2, a betacoronavirus, is the cause of the COVID-19 pandemic. The
SARS-CoV-2 spike (S) glycoprotein trimer mediates virus entry into host cells and cytopathic …

Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects

K Sharun, R Tiwari, M Iqbal Yatoo… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has spread to several
countries globally. Currently, there is no specific drug or vaccine available for managing …